MUTATION ISSUE OF CORONA
mutation issue
Survival of
the fittest the great line said by the great naturalist, geologist and
biologist Charles Robert Darwin. Is taken very seriously by corona virus that’s
why it mutated itself and had appeared in a new form with new
surprises. Viruses mutate all the time, including the novel coronavirus
that’s caused the global pandemic.
But a variant that emerged in southeast England in
September is causing particular concern, leading to an emergency lockdown in
London over Christmas and prompting countries including Canada, France and
Germany to halt flights and suspend
rail links to the U.K.
The variant is unusually highly
mutated.
The
most likely explanation is the variant has emerged in a patient with a weakened
immune system that was unable to beat the virus.
Instead
their body became a breeding ground for the virus to mutate.
UNDERSTANDING
THE MUTATION
Health officials in the United Kingdom
and around the world are worried about a new, seemingly more contagious variety
of SARS-CoV-2 (the virus that causes Covid-19), which has emerged in the
country and was announced over the weekend. The evidence that this new strain
spreads more easily between people is not rock solid, but it’s concerning
enough to have forced dramatic action.
An increasingly common mutation of the
novel coronavirus found in Europe, North America and parts of Asia may be more
infectious but appears less deadly, according to a prominent infectious
diseases doctor.
Paul Tambyah, senior consultant at the
National University of Singapore and president-elect of the International
Society of Infectious Diseases, said evidence suggests the proliferation of the
D614G mutation in some parts of the world
has coincided with a drop in death rates, suggesting it is less lethal.
mutants |
The new mutation of the coronavirus, that has emerged in the United Kingdom, has not been seen in India so far, officials from the Union Health Ministry told the media on Tuesday. The government also allayed fears over the new mutant strain stating that it does not affect the severity of the disease, but affects the transmissibility and infectiousness of the virus. Assuring that there is no need to panic, officials from the Health Ministry maintained that it is important to follow COVID-19 norms and precautions.
What is
N501Y?
In simple words, the
amino acid represented by the letter N, and present at position 501 in
the coronavirus genetic structure, has been replaced in that position with
another amino acid, represented by Y. The position where this alteration has
taken place is in the spike protein’s receptor-binding domain. (It is the spike
protein of the virus that binds with the human receptor.)
Therefore, the
mutation has increased the binding affinity of the coronavirus. The mutated
virus reportedly accounts for 60% of recent infections in London.
According to the Global Initiative on Sharing Avian Influenza Data (GISAID) database, the same mutation in the receptor binding domain has been independently reported in several countries including South Africa and Australia. Sequence analysis has shown that this mutation originated separately in the UK and South Africa.
And what
are P681H and HV 69/70?
P681H: This mutation has occurred in the amino acid
present at 681 — another position in the receptor-binding domain. Here the
amino acid P has been replaced with H. The US Centres for Disease Control (CDC) has said this is a site “with high
variability in coronaviruses”, and this specific mutation has also emerged
spontaneously multiple times. The WHO has said this mutation is of “biological
significance”.
Researchers have
earlier shown that this mutation can promote entry into respiratory epithelial
cells and transmission in animal models.
Recent samples
sequenced at the African Centre of Excellence for Genomics of Infectious
Diseases, Redeemer’s University, Nigeria has shown the P681H sequence there.
However, researchers say that at present, they “do not have evidence to
indicate that the P681H variant is contributing to increased transmission of
the virus in Nigeria”.
HV 69/70: This mutation is the result of a deletion of amino
acids at positions 69 and 70. These positions are again in the spike protein of
the virus. This deletion has been observed in France and South Africa as well.
The CDC has said: “This double deletion has occurred spontaneously many times,
and likely leads to a change in the shape of (i.e., a conformational change in)
the spike protein”.
Researchers on behalf
of COVID-19 Genomics Consortium UK (CoG-UK), which red-flagged the new variant
in the UK, have said in their preliminary report that this deletion was also
seen in a mink-associated outbreak in Denmark. In humans, this deletion has
been associated with another mutation, N439K, which again occurred the
receptor-binding domain.
The WHO has highlighted that this deletion can affect the performance of some RT-PCR tests that detect the novel coronavirus.
Why is
this variant causing concern?
Three things are coming
together that mean it is attracting attention:
- It is rapidly replacing other versions of the
virus
- It has mutations that affect part of the virus
likely to be important
- Some of those mutations have already been shown
in the lab to increase the ability of the virus to infect cells
All of these come
together to build a case for a virus that can spread more easily.
However, we do not
have absolute certainty. New strains can become more common simply by being in
the right place at the right time - such as London, which had only tier two
restrictions until recently.
But already the
justification for tier four restrictions is in part to reduce the spread of the
variant.
"Laboratory experiments are required, but do you want to wait weeks or months [to see the results and take action to limit the spread]? Probably not in these circumstances," Prof Nick Loman, from the Covid-19 Genomics UK Consortium, told me.
Will the
vaccines work against the new variant?
Almost certainly yes,
or at least for now.
All three leading
vaccines develop an immune response against the existing spike, which is why
the question comes up.
Vaccines train the
immune system to attack several different parts of the virus, so even though
part of the spike has mutated, the vaccines should still work.
the only hope |
"But if we let it add more mutations, then you start worrying," said Prof Gupta.
"This virus is
potentially on a pathway for vaccine escape, it has taken the first couple of
steps towards that."
Vaccine escape
happens when the virus changes so it dodges the full effect of the vaccine and
continues to infect people.
This may be the most
concerning element of what is happening with the virus.
This variant is just
the latest to show the virus is continuing to adapt as it infects more and more
of us.
A presentation by
Prof David Robertson, from the University of Glasgow on Friday, concluded:
"The
virus will probably be able to generate vaccine escape mutants."
That would put us in a position similar to flu, where the vaccines need to be regularly updated. Fortunately the vaccines we have are very easy to tweak.
FAQ
Q. How common is this variant?
=> Believed to have been first detected in September,
the strain moves fast and is becoming the dominant
variant, causing over 50% of infections in
London by December, said Patrick Vallance, UK government’s chief
scientific adviser.
Q. Is mutation in a virus abnormal?
=> viruses
mutate all the time. Most of the new variant die out. Sometimes they spread
without altering the virus behaviour. Occasionally, they trigger dramatic
changes.
Q. Is the new variant more dangerous?
=> The
new variant is spreading more rapidly than the original version, but it
is not believed to be more deadly. There is
currently no evidence that this strain causes more severe illness, as per an
official.
Q. Is it found only in UK?
=> While
the variant is found across the UK, it is heavily concentrated in London and
south east England. Instances
Of the same variant have been reported
in Denmark, Australia and Netherlands.
Q. How many days or years virus live
in a lab?
=> researchers
say that the virus may remain for 28-30 days in the lab which is equivalent to
on around one month. The
findings from Australia's national science agency suggest SARS-Cov-2 can
survive for far longer than thought.
No comments:
Post a Comment